ABC | Volume 113, Nº4, October 2019

Case Report Farias et al. Myocarditis due to Chikungunya/Dengue coinfection Arq Bras Cardiol. 2019; 113(4):783-786 1. Mayer SV, Tesh RB, Vasilakis N. The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers. Acta Tropica. 2017 Feb;166:155-63. 2. Pierson TC, DiamondMS. Flaviviruses. In: KnipeDM, Howley PM, Cohen IC (eds). 6th ed. Fields virology. Philadelphia:Wolters Kluwer, 2014.p.746-94. 3. DonalisioM, Freitas A, Zuben A. Arboviruses emerging in Brazil: challenges for clinic and implications for public health. Rev Saude Publica. 2017 Apr;51:30. 4. Brasil.MinistériodaSaúde.SecretariadeVigilânciaSanitária.Monitoramento dos casos de dengue , febre chikungunya e febre pelo vírus Zika. Boletim Epidemiológico. 2017;48(44):1-13. 5. Furuya-Kanamori L, Liang S, Milinovich G, Magalhaes RJS, Clements ACA, Hu W, et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infectious Diseases. 2016 Mar;16:84. 6. Alvarez MF, Bolívar-Mejía A, Rodriguez-Morales AJ, Ramirez-Vallejo E. Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: A systematic review. F1000Res. 2017;6:390. 7. ShivanthanM,NavinanM,ConstantineG,RajapakseS.Cardiac involvement in dengue infection. J Infect Dev Ctries. 2015;9(4):338-346. 8. Ramanathan K, Teo L, Raymond W, MacLaren G. Dengue Myopericarditis Mimicking AcuteMyocardial Infarction. Circulation. 2015;131(23):519-22. 9. Simon F, Paule P, Oliver M. Chikungunya virus-induced myopericarditis: toward an increase of dilated cardiomyopathy in countries with epidemics? Am J Trop Med Hyg. 2008;78(2):212-3. 10. Maiti CR, Mukherjee AK, Bose B, Saha GL. Myopericarditis following chikungunya virus infection. J Indian Med Assoc. 1978;70(11):256-8. 11. Cunha RVD, Trinta KS. Chikungunya virus: clinical aspects and treatment - A Review. Mem Inst Oswaldo Cruz. 2017;112(8): 523-31. 12. Brizzi K. Neurologic Manifestation of Chikungunya Virus. Curr Infect Dis Rep. 2017;19(2):6. 13. Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3(1):35. 14. Bandyopadhyay D, Ghosh SK. Mucocutaneous manifestations of Chikungunya fever. Indian J Dermatol. 2010;55(1):64–7. 15. Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl J Med. 2012;366(15):1423-32. 16. AroraM, Patil RS. CardiacManifestation inDengue Fever. J Assoc Physicians India. 2016;64(7):40-4. 17. Kam YH, Pok KY, Eng KE, Tan LK, Kaur S, Lee WW, et al. Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients. PLoS Negl Trop Dis. 2015;9(1):e3445. 18. Wiwanitkit V. Dengue myocarditis, rare but not fatal manifestation. Int J Cardiol. 2006;112(1):122. 19. Obeyesekere I, Hermon Y. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever--a follow-up study. AmHeart J. 1973;85(2):186-94. 20. Mukherjee S, Dutta SK, Sengupta S, Tripathi A. Evidence of dengue and chikungunya virus co-infection and circulation of multiple dengue serotypes in a recent Indian outbreak. Eur J Clin Microbiol Infect Dis. 2017;36(11):2273-9. 21. Prince HE, Matud JL. Estimation of Dengue Virus IgM Persistence Using Regression Analysis. Clin Vaccine Immunol. 2011;18(12):2183-5. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 786